The Medical Tourism Market to Be Driven By Digiceuticals

 As per Persistence Market Research’s latest industry analysis, the global medical tourism market was valued at US$ 162.7 Bn in 2020, and is expected to exhibit a CAGR of 10.2% over the forecast period (2021-2031).

Accessibility and affordability of high-quality healthcare facilities, health insurance portability, support from local governments and tourism departments, and increasing advertising and marketing strategies related to medical tourism are key factors driving market growth. Furthermore, availability of state-of-the-art medical technologies at medical tourism destinations is also supplementing market expansion.

Asian countries accounted for the largest market share due to their excellent healthcare facilities at relatively low cost of treatment, availability of inexpensive flights, and increase in marketing & online consumer information about the availability of medical services.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32740

Considering consolidation activities in the healthcare tourism industry, collaborations have emerged as a winning strategy by key players. Leading players are strengthening their services through partnerships and reaching out to key as well as emerging markets.

·         For instance, in January 2021, Changi General Hospital and Shimadzu (Asia Pacific) jointly launched a center to conduct mass spectrometry-based clinical testing and research for personalized treatment

·         In February 2021, Apollo Hospitals partnered with Anatomiz3D Medtech to establish Hospital 3D Printing Labs across India.

Company Profiles:

·         Penang Adventist Hospital

·         Twin Towers Medical Center

·         Institute Jantung Negara National Heart Institute

·         Max Superspeciality Hospital

·         Fortis Healthcare

·         Apollo Hospital

·         Morula IVF

·         Mother & Child Hospital

·         Bundamedik Healthcare System

·         Bali Mandara Hospital

·         Bali Royal Hospital

·         BIMC Siloam Nusa

·         Love the Mother of Kedonganan Hospital

·         Love Tabanan Hospital Mo

·         Singapore General Hospital

·         Changi General Hospital

·         Johns Hopkins Singapore International Medical Centre

·         Tan Tock Seng Hospital

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32740

global-medical-tourism-market

Key Takeaways from Market Study

·         Cancer treatment is expected to gain 74.1 Bn revenue by 2031 at a CAGR of 9.1%.

·         Based on age group, the adults segment accounted for the highest share of 45% in 2021. The segment witnessed high growth owing to rising awareness among adults for a healthy lifestyle.

·         Among the applications, therapeutic services gained popularity accounting for 53% market share, and the segment is expected to dominate throughout the forecast period at a growth rate of 9.4%.

·         Based on travellers, group travellers hold the highest revenue share of 54% at a growth rate of 9.3%.

·         North America accounted for the largest share in the global medical tourism market in 2020, and a similar trend is expected to continue during the forecast years.

“Higher treatment cost in developed countries is a key factor that is expected to drive demand for medical tourism across other regions over the coming years,” says an analyst of Persistence Market Research.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32740

Market Competition

Leading service providers continue to rely upon acquisitions, collaborations, alliances, and product launches to gain large revenue shares in the medical tourism market. As such, providing access to safe and effective treatment will remain key aspects to succeed in this competitive marketplace.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the global medical tourism market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on treatment (dental treatment, cosmetic treatment cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and others), age group (children, adolescents, adults, and geriatric), application (wellness services and therapeutic services), and traveller (independent travellers and group travellers), across seven key regions of the world.

 

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

Comments

Post a Comment

Popular posts from this blog

The Metabolomics Biomarker Market to Grow Beyond Linear Progression

  The Metabolomics Biomarker Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes. Metabolomics Biomarkers are used for discovery of new insights, assessment method and treatment options for pathological diseases other than the traditional ideas. Metabolites are small molecules which are responsible for cellular processes and metabolism in an organism. Metabolites are used for biomarker discovery by metabolite profiling in cells, tissues or biofluids. Biomarkers acts as indicators for response in the form of a biological process of a drug, toxin or therapy. Metabolomics biomarkers are also used to evaluate the progress of the di...
Read more

The Clinical Trial Management System Market to virtually grow beyond geographies

  The Clinical Trial Management System Market is all set to be in the driver’s seat shortly. Technology adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the form of granular applications. Technologies like DevOps and AIOps are constructively disrupting the healthcare IT sector and are expected to create wonders in this regard in the upcoming period. Persistence Market Research has recently published a  global market study on  clinical trial management systems . The market is estimated to be valued at  US$ 2 Bn  in 2021 and is expected to surge at a  CAGR of 14%  from 2021 to 2031, to reach an estimated value of  US$ 7 Bn  by the end of 2031. Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Globally, the CTMS market is witnessing significant growth due to i...
Read more

Customization of care to drive the Cardiovascular Information Systems Market

Image
  The Cardiovascular Information Systems Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare system. As the global healthcare industry addresses a paradigm shift towards coordinate care services, medical practitioners are compelled to develop databases for structuring case studies in the future. This necessitates the need for recording essential information on prevalent disorders such as cardiovascular diseases. A latest study developed by Persistence Market Research predicts that the demand for cardiovascular information systems will keep surging in the upcoming decade. And, rising adoption of structu...
Read more